Dalargin (Botkin Hospital)

N/A

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameDalargin (Botkin Hospital)
Drug Alias Namesynthetic analog of the endogenous opioid peptide leucine-enkephalin (Botkin Hospital)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Organ FailurePostoperative Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBotkin Hospital
China Registration ClassN/A

Develop Information

Active CompaniesBotkin Hospital
Inactive CompaniesN/A
Active IndicationsMultiple Organ FailurePostoperative Complications
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A